In this study, researchers want to find out how safe and effective it is to use two new drugs, alone or in combination, to treat recurrent, low grade serous ovarian cancer (LGSOC).The drugs used in this trial are both a type of drug called a kinase inhibitor. Kinase inhibitors block cancer cell growth.The drugs involved in this trial are:Defactinib…

In this trial, the researchers are trying to find out whether it's safe and effective to use a PARP inhibitor rather than standard chemotherapy in women with a BRCA gene mutation who've had two previous chemotherapy treatments. The drugs involved in this trial: Rucaparib – a targeted treatment known as a PARP inhibitor Paclitaxel – a sta…